dapagliflozin
Dapagliflozin is a medication used to treat type 2 diabetes by decreasing blood sugar levels. It belongs to a class of drugs called SGLT2 inhibitors, which work by preventing the kidneys from reabsorbing glucose, causing it to be excreted in the urine.
Requires login.
Related Concepts (1)
Similar Concepts
- biguanides
- canagliflozin
- dipeptidyl peptidase-4 (dpp-4) inhibitors
- dipeptidyl peptidase-4 inhibitors
- empagliflozin
- insulin degludec
- insulin glargine
- insulin glulisine
- liraglutide
- meglitinides
- oral glucose-lowering medications
- pioglitazone
- sitagliptin
- sodium-glucose cotransporter-2 inhibitors
- sulfonylureas